Expansion6 May 2026, 07:01 pm
Kabra Drugs Expands Pharma Manufacturing & AI Defense Tech
AI Summary
Kabra Drugs Ltd has announced strategic initiatives approved by its Board, focusing on pharmaceutical manufacturing expansion, AI-integrated defense technologies, and advanced R&D. The company will expand pharmaceutical manufacturing and marketing of generic branded formulations in phases, starting with South India. It will also pursue AI-driven defense manufacturing, including establishing an AI & defense Technology R&D facility at Cactus TECCI Park, Chennai. Mr. Alagiamanavalan has been appointed as an Independent Consultant for defense projects. These initiatives aim to diversify the company, foster innovation, and create long-term value.
Key Highlights
- Kabra Drugs to expand pharmaceutical manufacturing and marketing of generic formulations.
- Company to establish AI & defense Technology R&D facility in Chennai.
- Mr. Alagiamanavalan appointed as Independent Consultant for defense projects.
- Expansion to be executed through strategic channel partners arranged by 'Mr. Franchise'.
- Company to initiate regulatory approval process with DGFT for SCOMET License.